Juniper Pharma (Formerly known as Columbia Laboratories)
4 Liberty Square
Boston
Massachusetts
02109
United States
Tel: 617-639-1500
Website: http://www.juniperpharma.com/
Email: enquiry@juniperpharma.com
274 articles about Juniper Pharma (Formerly known as Columbia Laboratories)
-
Columbia Laboratories, Inc. Acquires Exclusive Worldwide License To A Novel Segmented Intra-Vaginal Ring Delivery Technology
3/30/2015
-
Columbia Laboratories, Inc. Reports Fourth Quarter And Full-Year 2014 Financial Results
3/18/2015
-
Columbia Laboratories, Inc. Release: Federal Appeals Court Affirms Dismissal Of Class Action Lawsuit
3/12/2015
-
Columbia Laboratories, Inc. To Discuss Fourth Quarter And Full Year 2014 Financial Results On March 18th Conference Call
3/11/2015
-
Columbia Laboratories, Inc. To Present At The 27th Annual ROTH Conference
3/3/2015
-
Columbia Laboratories, Inc. To Initiate A Phase 2 Clinical Trial For COL-1077, Lidocaine Bioadhesive 10% Gel, In The Second Quarter Of 2015
2/26/2015
-
Columbia Laboratories, Inc. Announces Date Of 2015 Annual Meeting Of Stockholders
2/6/2015
-
Columbia Laboratories, Inc. To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/2/2015
-
Columbia Laboratories, Inc. Announces Search For New Board Member, Impending Retirement Of Chairman Stephen G. Kasnet; Amendment To Increase Permissible Ownership Levels Under Shareholder Rights Plan
1/29/2015
-
Columbia Laboratories, Inc. Announces Appointment Of Chief Medical Officer
1/6/2015
-
Columbia Laboratories, Inc. Reports Third Quarter 2014 Financial Results
10/28/2014
-
Columbia Laboratories, Inc. To Discuss Third Quarter 2014 Financial Results On October 28th Conference Call
10/14/2014
-
Columbia Laboratories, Inc.' UK Subsidiary To Launch New Development Platform At CPHI
10/1/2014
-
Columbia Laboratories, Inc. Announces Appointment Of New Chief Financial Officer
9/24/2014
-
Columbia Laboratories, Inc. Announces Completion Of CRINONE License Renewal
9/8/2014
-
Columbia Laboratories, Inc. To Participate In The Rodman & Renshaw16th Annual Global Investment Conference
8/27/2014
-
Columbia Laboratories, Inc. Announces Sale Of IP And Technology For Legatrin P.M. To Lil' Drug Store Products
8/6/2014
-
Columbia Laboratories, Inc.'s Subsidiary, Molecular Profiles, Strikes Alliance With XenoGesis Ltd.
7/31/2014
-
Columbia Laboratories, Inc. Reports Second Quarter 2014 Financial Results
7/31/2014
-
Columbia Laboratories, Inc. To Discuss Second Quarter 2014 Financial Results On July 31st Conference Call
7/23/2014